“I am a certified speech-language pathologist with over 10 years of experience in the field and I have decided to challenge myself with new learnings and experiences outside of the traditional speech-pathology world. Therefore, after completing orofacial motricity training and the use of photobiomodulation. I decided to complete the THOR training and it was an excellent experience. I learned about the safety of the devices and the significant benefits that it can provide to patients of all needs. I highly recommend this course and hope you have the same positive experience that I did. Thank you very much, THOR!”
Karla Estrada-Rojas MA, CCC-SLP
Bilingual Speech-Language Pathologist
Embrace Your Speech, LLC – Owner
Matawan NJ, USA
“An evidence based, honest and unbiased training course. All topics were great, especially the information about the intra-cavitary probe for benign prostatic hypertrophy. All around excellent presentation. I will have another member of our team attend the next presentation.”
Sy Coolidge Pierre, M.D.
Consultant Physician & Anaesthetist
“The training course was great! I liked the science behind it/so many variables, and the growth of THOR how they keep developing new probes for different protocols. Thank you so much! I really enjoyed the presentation. There was so much information!”
For several years after the birth of her second child, Yendi Jackson started having seizures on her menstrual cycle. Yendi would have severe migraines and then she would start to seize. Yendi had been on 13 different seizure medications and been in the ICU because of her seizures.
She has been through a lot and needed a better solution. She went to a session that Xscape Pain were offering and decided to try NovoTHOR and wouldn’t be without it now. It’s become part of her routine and she is loving having her energy back.
“The 8 hour course with James was excellent. I have an interest in learning more about PBM and how to help my cardiovascular patients. This course explained the basic mechanisms how PBM work via improving energy production from the mitochondria. Case reports and studies were provided. Questions were answered.
Great course and highly recommended to all who want to learn more about PBM.”
Saint Louis MO, USA
Tabitha Barnes has been going to Xscape Pain for about two months now, twice a week and she wishes she could go everyday! The NovoTHOR Bed has done wonders for Tabitha as she finally gets relief in her previously aching joints, hips and lower back. She has lost weight, gained back her energy, and overall feels more like herself.
Stroke patient Ronnie and his lovely wife Lonnie share their experience of neurologic recovery using photobiomodulation therapy.
Ronnie had a stroke in 2012, he died on the way to hospital, but came to 3 days later. He couldn’t walk, he couldn’t talk or eat and tried everything for years until he came to Advantage Therapy Solutions and started getting amazing results.
Christie has had temporomandibular joint (TMJ) for 15 years and went to Advantage Therapy Solutions when she was having really bad pain. The treatments have really helped a lot right from the start. After the first session, Christie was feeling relief from the pain and it continued to get better after that. She has not felt this good in a really long time.
Steve went to Laser Therapy Sydney to seek treatment for his Ramsay Hunt – facial nerve palsy as a result of shingles (Herpes Zoster reactivation).
After the Photobiomodulation treatments, Steve felt improvement almost immediately and it helped him regain movement of the right side of his face, eliminated his post-herpetic neuralgia and relieved his chronic lower back pain. He’s feeling fantastic and recommends Photobiomodulation to anyone.
U.S. CONGRESSIONAL BRIEFING. Ending Opioid Use – Washington DC
James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.
“We are loving our THOR. It’s being implemented into our surgery protocols, as well as our rehabilitation department. We are also using it for wound care and various other therapies in our general practice. Absolutely loving it.
Latest great success story was a cat with kidney failure and severe colitis that used the therapy and was feeling good enough to jump up on the counter and look at the birds. The owner loved seeing her little old kitty acting like a younger cat again after his treatments.”
A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in health care, direct health care costs and lost productivity because of pain.
49,000 people from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.
We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).
The paper “High-intensity versus low-level laser therapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial” Kheshie et al 2014 pitches the 3B BTL laser against the HIRO class IV “High intensity” laser. The results appear to show that the HIRO class IV “High intensity laser” was more effective than the “Low Level Laser”. HOWEVER, the HIRO class IV “High intensity” laser was delivered over a large area (not adequately defined but approx 100cm2 by my estimation) so the intensity was actually very low (about 13mW/cm2 which is less than most LED systems), and the 3B BTL “Low Level Laser” was actually very high (4 x 200mW small, high intensity beams) and were held stationary on the patella for over half an hour, YES, HALF AN HOUR IN ONE SPOT! This is insane.
This paper leads people to think that the class IV Hiro laser was more effective because it was higher intensity when in fact the beam distribution meant the average intensity distribution was low (13mW/cm2). The 3B laser was not so effective because it was held stationary such that it would cause an overdose. If the 3B laser treatment had been delivered in using same scanning technique as the class IV then they would likely have achieved the same result. (I am not a fan of scanning because you can never be sure how much energy you have delivered to an area, better to use a low intensity device and hold it still in my view).
This paper misdirects the reader towards favouring class IV lasers rather than 3b or LED by misinforming the reader.
The title of last months PMLS editorial was Low Level Laser Therapy (LLLT) and World Association for Laser Therapy (WALT) Dosage Recommendations. Written by the Scientific Secretary Prof. Jan Bjordal. He describes how far we have come and the importance of the WALT dosage recommendations. No abstract is available for editorials so I have prepared one for you below. Continue reading →
A paper titled ”The Effectiveness of Therapeutic Class IV (10 W) Laser Treatment for Epicondylitis” [ref] showed that 10 Watt Class IV laser (mixed 8W 970nm, 2W 810) was successful in reducing pain and improving function in an RCT with 15 patients, and that there was good statistical significance at 6 months following a course of 6 treatments.
The claim by class IV laser manufacturers is that class IV lasers are better (faster, deeper and more effective) than Class 3b and LED systems. Conversely the 3B laser and LED manufacturers argue that less power density is more effective because delivering energy too quickly can overdose tissues and class IV lasers might burn the skin.
Throughout this paper there are marketing messages claiming the advantages of shorter treatment times than low power LLLT systems and of course the title shouts “10 Watt Class IV laser” just in case the reader is in any doubt that more power is what you need.
Regular readers of this column know my obsession with irradiation parameters, particularly dose rate effects (W/cm2) and will not be surprised to learn that I deconstruced the irradiation parameters used in this trial . Surprise, surprise they were the same low irradiance levels typically used by 3B lasers and LED systems, if not less and the treatment time was longer too.
Yes, it was a 10 Watt laser and yes, 3,000 joules was delivered, however it had a large beam area and treatment was delivered over (45cm2) in a “painting fashion”. The fluence (dose) was 6.6 Joules/cm2 and the power density was a tiny 22mW/cm2, consequently treatment time was a hefty 5 mins.
The average irradiance was not disclosed in the paper and the reader is directed to think that more power is quicker.
P.S. research trials with 3B lasers are typically 30 seconds to 3 mins and our recommended treatment is 1 min with a large LED cluster to the lateral epicondyle and 30 seconds for any related trigger points.
The Treatment Protocol Library is available only to THOR Customers and/or people who have attended a THOR training course in the last 3 years. All treatments are based on our four step method which includes treatment of the injury, trigger points, lymphatics and nerve roots.
Take a look to see how it works and let us know what you think.